NCT04300400

Brief Summary

Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are not always clear on the treatment management of drug therapy resistant OAB. Standardization in OAB treatment is needed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 16, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 7, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 9, 2020

Completed
Last Updated

January 19, 2023

Status Verified

January 1, 2023

Enrollment Period

9 months

First QC Date

February 7, 2020

Last Update Submit

January 17, 2023

Conditions

Overactive Bladder Syndrome

Keywords

Overactive bladder SyndromeDelphi studyTreatment algorithm

Outcome Measures

Primary Outcomes (1)

  • Degree of consensus on the level of appropriateness

    No consensus, trend towards consensus or consensus

    8 months

Study Arms (1)

Delphi panel

Urologists of the Belgian Working group of Functional Urology willing to participate on the Delphi project.

Other: Delphi questionnaire

Interventions

Delphi questionnaireOTHER

Statements on OAB topics, rated along their level of appropriateness on a scale from 1 to 9. Multiple rounds are organised to reach consensus on a topic.

Delphi panel

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Belgian Urologists: members of the working group of Functional Urology.

You may qualify if:

  • Profession: MD, Urologist
  • Member of the working group of Functional Urology

You may not qualify if:

  • Retirement
  • Non-operative as an urologist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, East-Flanders, 9000, Belgium

Location

Study Officials

  • Lynn Ghijselings, MD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2020

First Posted

March 9, 2020

Study Start

October 16, 2018

Primary Completion

July 23, 2019

Study Completion

September 10, 2019

Last Updated

January 19, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations

BE(1)